BioCatalyst

TPB — Turning Point Brands, Inc. catalysts

1 verified catalyst event(s) for Turning Point Brands, Inc. (ticker TPB). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-09-30 — A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTR · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-30
in 3mo
ESTIMATED
 READOUT
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, RO
Phase 1/2 · Locally Advanced Solid Tumors, Metastatic Solid Tumors
 TPB Turning Point Brands, Inc. Oral repotrectinib (TPX-0005) ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.